1. Home
  2. FLNT vs ATRA Comparison

FLNT vs ATRA Comparison

Compare FLNT & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fluent Inc.

FLNT

Fluent Inc.

HOLD

Current Price

$3.50

Market Cap

96.1M

ML Signal

HOLD

Logo Atara Biotherapeutics Inc.

ATRA

Atara Biotherapeutics Inc.

N/A

Current Price

$9.49

Market Cap

94.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FLNT
ATRA
Founded
2010
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
96.1M
94.2M
IPO Year
2009
2014

Fundamental Metrics

Financial Performance
Metric
FLNT
ATRA
Price
$3.50
$9.49
Analyst Decision
Hold
Sell
Analyst Count
1
2
Target Price
$3.50
$5.00
AVG Volume (30 Days)
31.4K
41.7K
Earning Date
05-14-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
41.67
122.52
EPS
N/A
N/A
Revenue
$208,764,000.00
$120,772,000.00
Revenue This Year
$5.89
N/A
Revenue Next Year
$12.62
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.70
$3.92
52 Week High
$4.49
$19.15

Technical Indicators

Market Signals
Indicator
FLNT
ATRA
Relative Strength Index (RSI) 49.61 50.57
Support Level $2.94 $8.98
Resistance Level $3.52 $10.02
Average True Range (ATR) 0.23 0.70
MACD 0.04 -0.02
Stochastic Oscillator 76.39 26.09

Price Performance

Historical Comparison
FLNT
ATRA

About FLNT Fluent Inc.

Fluent Inc is a commerce media solutions provider that connects brands with engaged consumers by leveraging diverse advertising inventory, robust first-party data, and proprietary machine learning. The company mainly delivers customer acquisition services through scalable digital marketing campaigns, linking advertisers with targeted audiences. It reaches consumers through its Commerce Media Solutions, which integrate targeted advertising into e-commerce and digital media transaction flows on partner websites and mobile applications, as well as through its owned and operated digital media properties. The company operates in the United States, which generates the majority of its revenue, along with international markets.

About ATRA Atara Biotherapeutics Inc.

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA3431, and ATA3219.

Share on Social Networks: